Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases-Reference-Cited by-同舟云学术

Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases

Published:2019-01 Issue: Volume:233 Page:57-64
ISSN:0022-4804
Container-title:Journal of Surgical Research
language:en
Short-container-title:Journal of Surgical Research

Author:

Qin Jianzhong,Kunda Nicholas M.,Qiao Guilin,Tulla Kiara^ORCID,Prabhakar Bellur S.,Maker Ajay V.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Surgery

Reference46 articles.

1. International trends in colorectal cancer incidence rates;Center;Cancer Epidemiol Biomarkers Prev,2009

2. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel;Nordlinger;Ann Oncol,2009

3. Immunotherapy for colorectal cancer;Boland;Cancers (Basel),2017

4. Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer;Chung;J Clin Oncol,2010

5. PD-1 blockade in tumors with mismatch-repair deficiency;Le;New Engl J Med,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review;Frontiers in Pharmacology;2023-04-21

2. Contribution of natural killer cells in innate immunity against colorectal cancer;Frontiers in Oncology;2023-01-04

3. Leveraging tumor cell ferroptosis for colorectal cancer treatment via nanoelicitor-activated tumoricidal immunity;Chemical Engineering Journal;2022-02

4. Advances in heterocycles as DNA intercalating cancer drugs;Physical Sciences Reviews;2022-01-05

5. Co-delivery of proanthocyanidin and mitoxantrone induces synergistic immunogenic cell death to potentiate cancer immunotherapy;Biomaterials Science;2022